Patents by Inventor Lee Josephson

Lee Josephson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11779661
    Abstract: The present disclosure provides nucleic acid binding nanoprobes having one or more fluorochromes and a polymer, where each of the fluorochromes is connected to the polymer, and methods of using the same.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: October 10, 2023
    Assignee: The General Hospital Corporation
    Inventors: David Sosnovik, Lee Josephson, Howard Chen
  • Patent number: 10688201
    Abstract: A method of synthesizing a radiolabeled nanoparticle. The method includes heating a solution including an iron oxide nanoparticle and at least one radioactive metal ion to bind the iron oxide nanoparticle and the at least one radioactive metal ion, thereby forming the radiolabeled nanoparticle. The method further includes adding a quenching agent to the solution to complex with non-bound radioactive metal ions remaining in the solution. The method further includes separating the complexed quenching agent from the radiolabeled nanoparticle.
    Type: Grant
    Filed: October 9, 2014
    Date of Patent: June 23, 2020
    Assignee: The General Hospital Corporation
    Inventors: Jason Philip Holland, Lee Josephson
  • Publication number: 20190269802
    Abstract: The present disclosure provides nucleic acid binding nanoprobes having one or more fluorochromes and a polymer, where each of the fluorochromes is connected to the polymer, and methods of using the same.
    Type: Application
    Filed: November 8, 2017
    Publication date: September 5, 2019
    Inventors: David Sosnovik, Lee Josephson, Howard Chen
  • Publication number: 20190113508
    Abstract: The present invention provides novel compositions of binding moiety-nanoparticle conjugates, aggregates of these conjugates, and novel methods of using these conjugates, and aggregates. The nanoparticles in these conjugates can be magnetic metal oxides, either monodisperse or polydisperse. Binding moieties can be, e.g., oligonucleotides, polypeptides, or polysaccharides. Oligonucleotide sequences are linked to either non-polymer surface functionalized metal oxides or with functionalized polymers associated with the metal oxides. The novel compositions can be used in assays for detecting target molecules, such as nucleic acids and proteins, in vitro or as magnetic resonance (MR) contrast agents to detect target molecules in living organisms.
    Type: Application
    Filed: May 8, 2018
    Publication date: April 18, 2019
    Inventors: Lee Josephson, Ralph Weissleder, J. Manuel Perez
  • Publication number: 20180120325
    Abstract: A method of obtaining fluorochromes that bind to specific sites on proteins is presented. The method consists of synthesizing a peptide bearing a sequence from a parent protein and a second peptide of similar composition but with a scrambled sequence. Each peptide is then added to a test fluorochrome at similar concentrations, and a difference in fluorescence is obtained. A difference in fluorescence indicates a sequence dependent interaction between the peptide and fluorochrome. A large number of fluorochromes can be screened using the two peptides to find one binding in a sequence dependent fashion. This fluorochrome can then be tested for binding to the original full-length protein. The fluorochrome can then serve as scaffold in medicinal chemistry. The fluorochrome/peptide interaction and resulting fluorescence can be inhibited by non-fluorescent test compounds, which are compounds that bind to this peptide. Thus.
    Type: Application
    Filed: October 10, 2017
    Publication date: May 3, 2018
    Applicant: MedChem Imaging
    Inventor: Lee Josephson
  • Publication number: 20160320379
    Abstract: The present invention provides novel compositions of binding moiety-nanoparticle conjugates, aggregates of these conjugates, and novel methods of using these conjugates, and aggregates. The nanoparticles in these conjugates can be magnetic metal oxides, either monodisperse or polydisperse. Binding moieties can be, e.g., oligonucleotides, polypeptides, or polysaccharides. Oligonucleotide sequences are linked to either non-polymer surface functionalized metal oxides or with functionalized polymers associated with the metal oxides. The novel compositions can be used in assays for detecting target molecules, such as nucleic acids and proteins, in vitro or as magnetic resonance (MR) contrast agents to detect target molecules in living organisms.
    Type: Application
    Filed: December 1, 2015
    Publication date: November 3, 2016
    Inventors: Lee Josephson, Ralph Weissleder, J. Manuel Perez
  • Publication number: 20160256581
    Abstract: A method of synthesizing a radiolabeled nanoparticle. The method includes heating a solution including an iron oxide nanoparticle and at least one radioactive metal ion to bind the iron oxide nanoparticle and the at least one radioactive metal ion, thereby forming the radiolabeled nanoparticle. The method further includes adding a quenching agent to the solution to complex with non-bound radioactive metal ions remaining in the solution. The method further includes separating the complexed quenching agent from the radiolabeled nanoparticle.
    Type: Application
    Filed: October 9, 2014
    Publication date: September 8, 2016
    Inventors: Jason Philip Holland, Lee Josephson
  • Patent number: 9284381
    Abstract: Multifunctional probes include a substrate (e.g., a nanoparticle, polymer, antibody, protein, low molecular weight compound, drug) and a multifunctional single-attachment-point (MSAP) reagent. The MSAP reagents can include three components: (i) a peptide scaffold, (ii) a single chemically reactive group on the peptide scaffold for reaction of the MSAP with a substrate having a complementary reactive group, and (iii) multiple functional groups on the peptide scaffold. The peptide scaffold can include any number of residues; however, for ease of synthesis and reproducibility in clinical trials, it is preferred to limit the residues in the peptide to 20 or less.
    Type: Grant
    Filed: July 9, 2013
    Date of Patent: March 15, 2016
    Assignee: The General Hospital Corporation
    Inventors: Lee Josephson, Elisabeth Garanger
  • Publication number: 20150258217
    Abstract: Fluorescent compounds include near infrared fluorochromes that are covalently linked to polyethylene glycol (PEG). The compounds behave like PEG in biological systems. One fluorescent compound has the formula (I): wherein R1 is a fluorescent moiety having an absorption wavelength maxima in the range of 450 to 1500 nanometers, R2 is a non-reactive moiety, and n is an integer. Another fluorescent compound has the formula (II): wherein R1 is a fluorescent moiety having an absorption wavelength maxima in the range of 450 to 1500 nanometers, R2 is a non-reactive moiety, R3 is a scaffold including an amino acid group, and n is an integer. The scaffold can be attached to a chelate, protein, enzyme, peptide, antibody, or drug that can target a site in a subject.
    Type: Application
    Filed: September 19, 2013
    Publication date: September 17, 2015
    Inventors: Peter Caravan, Lee Josephson, Yanyan Guo, Hushan Yuan
  • Patent number: 9097644
    Abstract: This invention relates generally to magnetic resonance (MR)-based methods and kits for measuring the viscosity of liquid samples.
    Type: Grant
    Filed: August 15, 2008
    Date of Patent: August 4, 2015
    Assignees: Massachusetts Institute of Technology, The General Hospital Corporation
    Inventors: Lee Josephson, Rui Hong, Michael J. Cima, Ralph Weissleder
  • Publication number: 20140303022
    Abstract: The present invention provides novel compositions of binding moiety-nanoparticle conjugates, aggregates of these conjugates, and novel methods of using these conjugates, and aggregates. The nanoparticles in these conjugates can be magnetic metal oxides, either monodisperse or polydisperse. Binding moieties can be, e.g., oligonucleotides, polypeptides, or polysaccharides. Oligonucleotide sequences are linked to either non-polymer surface functionalized metal oxides or with functionalized polymers associated with the metal oxides. The novel compositions can be used in assays for detecting target molecules, such as nucleic acids and proteins, in vitro or as magnetic resonance (MR) contrast agents to detect target molecules in living organisms.
    Type: Application
    Filed: April 18, 2014
    Publication date: October 9, 2014
    Applicant: The General Hospital Corporation
    Inventors: Lee Josephson, Ralph Weissleder, J. Manuel Perez
  • Publication number: 20140017816
    Abstract: This invention relates to magnetic resonance-based sensors and related methods.
    Type: Application
    Filed: September 13, 2013
    Publication date: January 16, 2014
    Applicant: The General Hospital Corporation
    Inventors: Lee Josephson, Yi Sun, Ralph Weissleder
  • Publication number: 20130295640
    Abstract: Multifunctional probes are synthesized in a single step using peptide scaffold-based multifunctional single-attachment-point reagents. To obtain multifunctional probes of the invention, a substrate (e.g., a nanoparticle, polymer, antibody, protein, low molecular weight compound, drug, etc.) is reacted with a multifunctional single-attachment-point (MSAP) reagent. The MSAP reagents can include three components: (i) a peptide scaffold, (ii) a single chemically reactive group on the peptide scaffold for reaction of the MSAP with a substrate having a complementary reactive group, and (iii) multiple functional groups on the peptide scaffold. The peptide scaffold can include any number of residues; however, for ease of synthesis and reproducibility in clinical trials, it is preferred to limit the residues in the peptide to 20 or less.
    Type: Application
    Filed: July 9, 2013
    Publication date: November 7, 2013
    Inventors: Lee Josephson, Elisabeth Garanger
  • Patent number: 8569078
    Abstract: The present invention provides novel compositions of binding moiety-nanoparticle conjugates, aggregates of these conjugates, and novel methods of using these conjugates, and aggregates. The nanoparticles in these conjugates can be magnetic metal oxides, either monodisperse or polydisperse. Binding moieties can be, e.g., oligonucleotides, polypeptides, or polysaccharides. Oligonucleotide sequences are linked to either non-polymer surface functionalized metal oxides or with functionalized polymers associated with the metal oxides. The novel compositions can be used in assays for detecting target molecules, such as nucleic acids and proteins, in vitro or as magnetic resonance (MR) contrast agents to detect target molecules in living organisms.
    Type: Grant
    Filed: May 3, 2010
    Date of Patent: October 29, 2013
    Assignee: The General Hospital Corporation
    Inventors: Lee Josephson, Ralph Weissleder, J. Manuel Perez
  • Patent number: 8546531
    Abstract: Multifunctional probes are synthesized in a single step using peptide scaffold-based multifunctional single-attachment-point reagents. To obtain multifunctional probes using the methods of the invention, a substrate (e.g., a nanoparticle, polymer, antibody, protein, low molecular weight compound, drug, etc.) is reacted with a multifunctional single-attachment-point (MSAP) reagent. The MSAP reagents can include three components: (i) a peptide scaffold, (ii) a single chemically reactive group on the peptide scaffold for reaction of the MSAP with a substrate having a complementary reactive group, and (iii) multiple functional groups on the peptide scaffold. The peptide scaffold can include any number of residues; however, for ease of synthesis and reproducibility in clinical trials, it is preferred to limit the residues in the peptide to 20 or less.
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: October 1, 2013
    Assignee: The General Hospital Corporation
    Inventors: Lee Josephson, Elisabeth Garanger
  • Patent number: 8535949
    Abstract: This invention relates to magnetic resonance-based sensors and related methods.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: September 17, 2013
    Assignee: The General Hospital Corporation
    Inventors: Lee Josephson, Yi Sun, Ralph Weissleder
  • Patent number: 8486373
    Abstract: An intramolecularly-quenched, near infrared fluorescence probe that emits substantial fluorescence only after interaction with a target tissue (i.e., activation) is disclosed. The probe includes a polymeric backbone and a plurality of near infrared fluorochromes covalently linked to the backbone at fluorescence-quenching interaction-permissive positions separable by enzymatic cleavage at fluorescence activation sites. The probe optionally includes protective chains or fluorochrome spacers, or both. Also disclosed are methods of using the intramolecularly-quenched, near infrared fluorescence probes for in vivo optical imaging.
    Type: Grant
    Filed: November 1, 2004
    Date of Patent: July 16, 2013
    Assignee: The General Hospital Corporation
    Inventors: Ralph Weissleder, Ching-Hsuan Tung, Umar Mahmood, Lee Josephson, Alexei Bogdanov
  • Patent number: 8420055
    Abstract: Amine functionalized magnetic nanoparticle compositions and processes for synthesizing the same are described. The process consists of obtaining a carboxylated polymer in substantially pure form, which is used to prepare a substantially size homogeneous, polymer coated carboxyl, functionalized magnetic nanoparticle. The carboxyl groups are converted to reactive primary amino groups by the use of a water-soluble carbodiimide followed by reaction of a large excess of a diamine. The amine-terminated nanoparticles are then reacted with bifunctional crosslinking agents and with various biomolecules to make nanoparticles for in vitro assays, cell sorting applications and target specific MR contrast agents.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: April 16, 2013
    Assignee: VisEn Medical, Inc.
    Inventors: Debra A. Gaw, Lee Josephson
  • Publication number: 20120121509
    Abstract: The present invention provides compositions and methods based on vital fluorochrome conjugates that are useful for imaging dying and dead cells.
    Type: Application
    Filed: June 4, 2010
    Publication date: May 17, 2012
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Lee Josephson, Elisabeth Garanger, Scott Hilderbrand, David Sosnovik, Hushan Yuan
  • Publication number: 20110159566
    Abstract: Multifunctional probes are synthesized in a single step using peptide scaffold-based multifunctional single-attachment-point reagents. To obtain multifunctional probes using the methods of the invention, a substrate (e.g., a nanoparticle, polymer, antibody, protein, low molecular weight compound, drug, etc.) is reacted with a multifunctional single-attachment-point (MSAP) reagent. The MSAP reagents can include three components: (i) a peptide scaffold, (ii) a single chemically reactive group on the peptide scaffold for reaction of the MSAP with a substrate having a complementary reactive group, and (iii) multiple functional groups on the peptide scaffold. The peptide scaffold can include any number of residues; however, for ease of synthesis and reproducibility in clinical trials, it is preferred to limit the residues in the peptide to 20 or less.
    Type: Application
    Filed: July 15, 2009
    Publication date: June 30, 2011
    Inventors: Lee Josephson, Elisabeth Garanger